Rilutek 50 mg tablets №56 (Рилутек / Riluzole / Рилузол)

Description of the drug

Rilutek (Rilutek) - is a drug based on the active substance riluzole (Riluzole), designed for slowing down the progression of amyotrophic lateral sclerosis (ALS). It is produced in the form of 50 mg tablets by Sanofi (France). The drug does not cure the disease, but can extend life expectancy and delay the need for artificial lung ventilation.

---

Indications for use

• Amyotrophic lateral sclerosis (ALS) - for slowing down the progression of the disease and preserving body functions.

---

Advantages of the drug

• Clinically proven slowing down of ALS progression

• Convenient dosage form - 50 mg tablets

• Original drug from Sanofi (France)

---

Method of application

Use only as directed by a doctor.
Recommended dose: 50 mg twice a day, 1 hour before meals or 2 hours after.

---

Who is suitable

• Adult patients with a confirmed diagnosis of amyotrophic lateral sclerosis (ALS).

• Not used in multiple sclerosis!

---

Search queries

This drug is also searched for as:
Rilutek, Rilutek, Riluzole, Riluzole, tablets for ALS, drug for amyotrophic lateral sclerosis, ALS treatment, Glentek, Teglutik, Exservan